Healthcare provider profile · identity verified

Rhett J Eckmann, MD

Emergency Medicine · WEST POINT, NE · NPI 1205922465

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	107
Amlodipine Besylate	Amlodipine Besylate	395	95
Levothyroxine Sodium	Levothyroxine Sodium	320	64
Furosemide	Furosemide	319	68
Omeprazole	Omeprazole	311	67
Lisinopril	Lisinopril	301	71
Metoprolol Succinate	Metoprolol Succinate	292	69
Eliquis	Apixaban	254	40
Gabapentin	Gabapentin	231	52
Pantoprazole Sodium	Pantoprazole Sodium	230	59
Tamsulosin Hcl	Tamsulosin Hcl	230	51
Potassium Chloride	Potassium Chloride	211	49
Losartan Potassium	Losartan Potassium	205	58
Metoprolol Tartrate	Metoprolol Tartrate	191	33
Warfarin Sodium	Warfarin Sodium	173	22
Simvastatin	Simvastatin	172	37
Rosuvastatin Calcium	Rosuvastatin Calcium	144	41
Tramadol Hcl	Tramadol Hcl	144	38
Allopurinol	Allopurinol	140	26
Metformin Hcl	Metformin Hcl	135	31
Spironolactone	Spironolactone	128	20
Meloxicam	Meloxicam	126	34
Prednisone	Prednisone	126	63
Clopidogrel	Clopidogrel Bisulfate	115	23
Fluticasone Propionate	Fluticasone Propionate	110	32
Hydrochlorothiazide	Hydrochlorothiazide	109	30
Mirtazapine	Mirtazapine	108	21
Trazodone Hcl	Trazodone Hcl	103	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	100	19
Metformin Hcl Er	Metformin Hcl	100	24
Mounjaro	Tirzepatide	95	12
Pioglitazone Hcl	Pioglitazone Hcl	94	20
Albuterol Sulfate Hfa	Albuterol Sulfate	88	42
Trulicity	Dulaglutide	88	12
Ropinirole Hcl	Ropinirole Hcl	81	13
Sertraline Hcl	Sertraline Hcl	77	18
Duloxetine Hcl	Duloxetine Hcl	72	11
Lorazepam	Lorazepam	69	22
Alendronate Sodium	Alendronate Sodium	68	16
Jardiance	Empagliflozin	66	14
Triamcinolone Acetonide	Triamcinolone Acetonide	64	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	19
Oxybutynin Chloride	Oxybutynin Chloride	60	suppressed
Montelukast Sodium	Montelukast Sodium	57	suppressed
Alprazolam	Alprazolam	55	16
Pregabalin	Pregabalin	53	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	14
Escitalopram Oxalate	Escitalopram Oxalate	48	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	48	suppressed
Donepezil Hcl	Donepezil Hcl	47	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Bumetanide	Bumetanide	45	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	45	32
Finasteride	Finasteride	44	suppressed
Loperamide	Loperamide Hcl	43	13
Torsemide	Torsemide	43	suppressed
Buspirone Hcl	Buspirone Hcl	42	suppressed
Myrbetriq	Mirabegron	42	suppressed
Chlorthalidone	Chlorthalidone	40	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	37	37
Famotidine	Famotidine	37	suppressed
Glipizide Er	Glipizide	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	36	31
Amiodarone Hcl	Amiodarone Hcl	34	suppressed
Cephalexin	Cephalexin	34	25
Colestipol Hcl	Colestipol Hcl	34	14
Enalapril Maleate	Enalapril Maleate	34	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Olanzapine	Olanzapine	34	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Azithromycin	Azithromycin	32	29
Clonazepam	Clonazepam	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Fentanyl	Fentanyl	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	29	29
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	29	suppressed
Digoxin	Digoxin	29	suppressed
Latanoprost	Latanoprost	28	suppressed
Tresiba Flextouch U-200	Insulin Degludec	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Hydrocortisone	Hydrocortisone	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	11
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Amoxicillin	Amoxicillin	22	19
Carvedilol	Carvedilol	22	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Nitroglycerin	Nitroglycerin	22	17
Nystatin	Nystatin	22	suppressed
Sulfasalazine	Sulfasalazine	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	17
Cefdinir	Cefdinir	19	16
Ibuprofen	Ibuprofen	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Ketoconazole	Ketoconazole	18	11
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Clonidine Hcl	Clonidine Hcl	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Movantik	Naloxegol Oxalate	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Primidone	Primidone	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Atenolol	Atenolol	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Albuterol Sulfate	Albuterol Sulfate	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Risperidone	Risperidone	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error